Journal of Cancer Research and Treatment
ISSN (Print): 2374-1996 ISSN (Online): 2374-2003 Website: Editor-in-chief: Jean Rommelaere
Open Access
Journal Browser
Journal of Cancer Research and Treatment. 2017, 5(2), 35-54
DOI: 10.12691/jcrt-5-2-2
Open AccessArticle

Garlic Induced Apoptosis, Cell Cycle Check Points and Inhibition of Cancer Cell Proliferation

Ravi Kant Upadhyay1,

1Department of Zoology, D. D.U. Gorakhpur University, Gorakhpur, 273009.U.P. India

Pub. Date: May 12, 2017

Cite this paper:
Ravi Kant Upadhyay. Garlic Induced Apoptosis, Cell Cycle Check Points and Inhibition of Cancer Cell Proliferation. Journal of Cancer Research and Treatment. 2017; 5(2):35-54. doi: 10.12691/jcrt-5-2-2


Present review article describing effects of garlic components on induction of apoptosis, cell cycle check points and inhibition of cancer cell proliferation. Garlic derived organic compounds hold unique therapeutic potential and induces apoptotic signaling pathways; do cell cycle arrest, and show cytotoxic and anti-invasive activity to a variety of cancer cells. Regular dietary intake of garlic cut down neoplastic growth, cancer cell proliferation, and induces programmed cell death. Garlic components act as tumor suppressor agents and prevent aberrant cell expansion by slowing down the cell cycle, or by inducing apoptosis. These apoptosis inducers can act on various apoptosis-related proteins to promote apoptotic cell death. Garlic based nanoformulations can target oncogenic mutations which disrupt apoptosis. These can inhibit cellular changes leading to tumor initiation, progression of metastasis. Garlic derivatives can control DNA damage thereby slow down oncogenic changes and induce caspase activity which halts or stalls mutation in p53 gene and thereby stops growth of lung, colon, and breast cancer. More often, new combinations of garlic components may stop cancer progression as well as multistage carcinogenesis. No doubt garlic components can be used in designing best possible molecular targets of cancer cells and that could be recommended for clinical management of different types of cancer.

garlic apoptosis antioxidants caspase protein histone deacetylation cell cycle check points tumor suppression

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  M.C. Rocio, and J. L. Rion, “A Review of Some Antimicrobial Substances Isolated from Medicinal Plants Reported in the Literature Review of Phytochemical Analysis on Garlic 1978-1972”. Phytother. Vol. 3, pp. 117-125. 1982.
[2]  J.A. Alli, B.E. Boboye, I.O. Okonko, A.F. Kolade, J.C. Nwanze, “In-Vitro assessments of the effects of garlic (Allium sativum) extract on clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus. Advances in Applied Science Research Vol. 2, pp. 25-36, 2011.
[3]  E. Block, “The chemistry of garlic and onions”. Sci Am. Vol.252, no. 3, pp. 114-119, 1985.
[4]  Y.L. Chu, R. Raghu, KH Lu, C.T. Liu, S.H. Lin, YS Lai, WC Cheng, SH Lin, LY Sheen, “Autophagy Therapeutic Potential of Garlic in Human Cancer Therapy”. J Tradit Complement Med. Vol. 3, no. 3, pp. 159-162, 2013.
[5]  T. Zeng, Y. Li, CL Zhang, LH Yu, ZP Zhu, XL Zhao, KQ Xie, “Garlic oil suppressed the hematological disorders induced by chemotherapy and radiotherapy in tumor-bearing mice”. J Food Sci. Vol. 78, no. 6, pp. 936-42, 2013.
[6]  Z.Y. Jin, M Wu, R.Q. Han, X.F. Zhang, X.S. Wang, A.M. Liu, J.Y. Zhou, Q.Y. Lu, Z.F. Zhang, J.K. Zhao, “Raw garlic consumption as a protective factor for lung cancer, a population-based case-control study in a Chinese population”. Cancer Prev Res (Phila), Vol. 6, no. 7, pp. 711-8, 2013.
[7]  B. Zhu, L. Zou, L. Qi, R. Zhong, X. Miao, “Allium Vegetables and Garlic Supplements do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies”. Clin Gastroenterol Hepatol. pii: S1542-3565, no. 14, pp. 00451-0.
[8]  C.A. González, N.Travier, L. Luján-Barroso, X. Castellsagué, F.X. Bosch, E. Roura, H.B. Bueno-de-Mesquita, D. Palli, “Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study”. Int J Cancer. Vol. 129, no. 2, pp. 449-59. 2011.
[9]  B. Aggarwal, S. Prasad, B. Sung, S. Krishnan, S.Guha, “Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature”. Curr Colorectal Cancer Rep. Vol. 9, no. 1, pp. 37-56, 2013.
[10]  G.Q. Yang, D. Wang, Y.S. Wang, Y. Y. Wang, K. Yang, “Radiosensitization effect of black garlic extract on lung cancer cell line Lewis cells”. Zhongguo Zhong Xi Yi Jie He Za Zhi. Vol. 33, no. 8, pp. 1093-7, 2013.
[11]  D.H. Alpers, “Garlic and its potential for prevention of colorectal cancer and other conditions”. Curr Opin Gastroenterol. Vol. 25, no. 2, pp. 116-21, 2009.
[12]  M. Dong, G. Yang, H. Liu, X. Liu, S. Lin, D. Sun, Y. Wang, “Aged black garlic extract inhibits HT29 colon cancer cell growth via the PI3K/Akt signaling pathway”. Biomed Rep. Vol. 2, no. 2, pp. 250-254, 2014.
[13]  W. Zhang, H. Xiao, K.L. Parkin, “Apoptosis in MCF-7 breast cancer cells induced by S-alkenylmercaptocysteine (CySSR) species derived from Allium tissues in combination with sodium selenite”. Food Chem Toxicol.68C, pp. 1-10, 2014.
[14]  G.C. Wallace, C.P. Haar, W.A. Vandergrift, P. Giglio, Y.N. Dixon-Mah, A.K. Varma, S.K. Ray, S.J. Patel, N.L. Banik, A. Das, “Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition”. J Neurooncol. Vol. 114, no. 1, pp. 43-50, 2013.
[15]  Nohara T, Fujiwara Y, Ikeda T, Murakami K, Ono M, Nakano D, Kinjo J. Cyclic sulfoxides garlicnins B2, B3, B4, C2, and C3 from Allium sativum. Chem Pharm Bull (Tokyo). Vol. 61, no. 7, pp. 695-9. 2013.
[16]  E. Appel, A.Rabinkov, M. Neeman, F. Kohen, D. Mirelman, “Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma”. J Drug Target.Vol.19, no. 5, pp. 326-35, 2011.
[17]  S.S. Shord, K. Shah, A. Lukose, “Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals”. Integr Cancer Ther. Vol. 8, no. (3), pp. 208-27, 2009.
[18]  C.H.Kaschula, R. Hunter, M.I. Parker, “Garlic-derived anticancer agents: structure and biological activity of ajoene”. Biofactors. Vol. 36, no. 1, pp. 78-85, 2010.
[19]  Omar S. H. Al-Wabel N. A. Organosulfuric compounds and possible mechanism of garlic in cancer. 2010; 18(1); 51-58.
[20]  S. Quintero-Fabián, D. Ortuño-Sahagún, M. Vázquez-Carrera, R.I. López-Roa, “Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes”. Mediators Inflamm. 381815, 2013.
[21]  M. Jo, H.M. Yun, K.R. Park, M.H. Park, D.H. Lee, S.H. Cho, H.S. Yoo, Y.M. Lee, H.S. Jeong, Y. Kim ,J.K. Jung,B.Y. Hwang,M.K. Lee, N.D. Kim, S.B. Han, J.T. Hong, “Anti-Cancer Effect of Thiacremonone through Down Regulation of Peroxiredoxin 6”. PLoS One. Vol. 9, no. 3, e91508, 2014.
[22]  J.O. Ban, H.S. Lee, H.S. Jeong, S. Song, B.Y. Hwang, D.C. Moon, Y. Yoon, do, S.B. Han, J.T. Hong, “Thiacremonone augments chemotherapeutic agent-induced growth inhibition in human colon cancer cells through inactivation of nuclear factor-{kappa}” B. Mol Cancer Res. Vol. 7, no.6, pp. 870-9, 2009.
[23]  N.J. Shaheen, C. Hur, “Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus”. Gastroenterology. Vol. 145, no. 2, pp. 273-6, 2013.
[24]  C. Busch, C. Jacob, A. Anwar, T. Burkholz, L. Aicha, Ba, C. Cerella, M. Diederich, W. Brandt, L. Wessjohann, M. Montenarh, “Diallylpolysulfides induce growth arrest and apoptosis”. Int J Oncol. Vol. 36, no.3, pp.743-9, M., 2010.
[25]  E.S. Alnemri, D.J. Livingston, D.W. Nicholson, G. Salvesen, N.A. Thornberry, W.W. Wong, J. Yuan, “Human ICE/CED-3 protease nomenclature”. Vol. 87, no. 2, pp. 171, 1996.
[26]  Entrez Gene: CASP3 caspase 3, apoptosis-related cysteine peptidase.
[27]  S. Ghavami, M. Hashemi, S.R. Ande, B. Yeganeh, W. Xiao, M. Eshraghi, C.J. Bus, K. Kadkhoda, E. Wiechec, A.J. Halayko, M. Los, “Apoptosis and cancer: mutations within caspase genes”. J. Med. Genet. Vol. 46, no. 8, pp. 497-510, 2009.
[28]  D.Y. Shin, H.J. Cha, G.Y. Kim, W.J. Kim, Y.H. Choi, “Inhibiting invasion into human bladder carcinoma 5637 cells with diallyl trisulfide by inhibiting matrix metalloproteinase activities and tightening tight junctions”. Int J Mol Sci. Vol. 14, no. 10, pp.19911-22, 2013.
[29]  H. Vakifahmetoglu-Norberg, B. Zhivotovsky, “The unpredictable caspase-2: what can it do?” Trends Cell Biol. Vol. 20, pp.150-159, 2010 .
[30]  H.B. Ma, S. Huang, X.R. Yin, Y. Zhang, Z.L. Di. “Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells”. World J Gastroenterol. Vol. 20, no. (1), pp. 193-203, 2014.
[31]  N.N. Danial, S.J. Korsmeyer, “Cell death: critical control points” Cell. Vol. 116, pp. 205-219, 2004.
[32]  J.F. Kerr, A.H. Wyllie, A.R. Currie, “Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics”, Br. J. Cancer, Vol. 26, pp. 239-257, 1972.
[33]  J.C. Reed, “Bcl-2 family proteins”, Oncogene Vol. 17, pp. 3225-3236, 1998.
[34]  X. Lan, H. Sun, J. Liu, Y. Lin, Z. Zhu, X. Han, X. Sun, X. Li, H. Zhang, Z. Tang, “Effects of garlic oil on pancreatic cancer cells”. Asian Pac J Cancer Prev. Vol.14, no. 10, pp. 5905-10, 2013.
[35]  Z. Xu, H. Wang, Y. Chen, G. Mao, Y. Hu, T. Zeng, K. Xie, “Preventive effects of garlic oil against the benzene-induced hematotoxicity in mice”. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. Vol. 32, no. 5, pp. 373-5, 2014.
[36]  H.K. Na, E.H. Kim, M.A. Choi, J.M. Park, D.H. Kim, Y.J. Surh, “Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1”. Biochem Pharmacol. Vol. 84, no. 10, pp. 1241-50, 2012.
[37]  J.H. Cha, Y.J. Choi, S.H. Cha, C.H. Choi, W.H. Cho, “Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway”. Oncol Rep. Vol. 28, no. 1, pp. 41-8, 2012.
[38]  Y.L. Chu, C.T. Ho, J.G. Chung, R. Rajasekaran, L.Y. Sheen, “Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells”. J Agric Food Chem. Vol. 60, no. 34, pp. 8363-71, 2012.
[39]  Y.B. Wang, J. Qin, X.Y. Zheng, Y. Bai, K. Yang, L.P. Xie, “Diallyl trisulfide induces Bcl-2 and caspase-3-dependent apoptosis via downregulation of Akt phosphorylation in human T24 bladder cancer cells”. Phytomedicine. Vol. 17, no. 5, pp. 363-8, 2010.
[40]  W. Zhang, M. Ha, Y. Gong, Y. Xu, N. Dong, Y. Yuan, “Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways”. Oncol Rep. Vol. 24, no. 6, pp. 1585-92, 2010.
[41]  W. Bat-Chen, T. Golan, I. Peri, Z, Ludmer, B. Schwartz, “Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2.” Nutr Cancer. Vol. 62(7), pp. 947-57, 2010.
[42]  M. Kelkel, C. Cerella, F. Mack, T. Schneider, C. Jacob, M. Schumacher, M. Dicato, M. Diederich, “ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis”. Carcinogenesis. Vol. 33, no. 11, pp. 2162-71, 2012.
[43]  C.S.Yu, A.C. Huang, K.C. Lai, Y.P. Huang, M.W. Lin, J.S. Yang, J.G. Chung, “Diallyl trisulfide induces apoptosis in human primary colorectal cancer cells”. Oncol Rep. Vol. 28, no. 3, pp. 949-54, 2012.
[44]  Y. Lee, H. Kim, J. Lee, K. Kim, “Anticancer activity of S-allylmercapto-L-cysteine on implanted tumor of human gastric cancer cell’. Biol Pharm Bull. Vol. 34, no. 5, pp. 677-81, 2011.
[45]  M. Murai, T. Inoue, M. Suzuki-Karasaki, T. Ochiai, C. Ra , S. Nishida, Y. Suzuki-Karasaki, “Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis”. Int J Oncol. Vol. 41, no. 6, pp. 2029-37, 2012.
[46]  L. Li, T. Sun, J. Tian, K. Yang, K. Yi, P. Zhang, “Garlic in clinical practice: an evidence-based overview”. Crit Rev Food Sci Nutr. Vol. 53, no. 7, pp. 670-81, 2013.
[47]  P. Dasgupta, S.S. Bandyopadhyay, “Role of di-allyl disulfide, a garlic component in NF-κB mediated transient G2-M phase arrest and apoptosis in human leukemic cell-lines”. Nutr Cancer. Vol. 65, no. 4, pp. 611-22, 2013.
[48]  Malki A, El-Saadani M, Sultan AS. Garlic constituent diallyl trisulfide induced apoptosis in MCF7 human breast cancer cells. Cancer Biol Ther. 2009; 8(22): 2175-85.
[49]  Knowles, L.M., Milner, J.A., 2001. Possible mechanism by which allyl sulfides suppress neoplastic cell proliferation. J Nutr.; Vol. 131, no. 3s, 1061S-1066S.
[50]  H.J. Sun, L.Y. Meng, Y. Shen ,Y.Z. Zhu, H.R. Liu, “S-benzyl-cysteine-mediated cell cycle arrest and apoptosis involving activation of mitochondrial-dependent caspase cascade through the p53 pathway in human gastric cancer SGC-7901 cells”. Asian Pac J Cancer Prev. Vol. 14, no.11, pp. 6379-84, 2013.
[51]  T.A. Miller, J.Witter, David, S. Belvedere, “Histone Deacetylase Inhibitors”. Journal of Medicinal Chemistry, Vol. 46, no. 24, pp. 5097-116, 2003.
[52]  Mwakwari, Sandra., V. Patil, W. Guerrant, A. Oyelere, “Macrocyclic Histone Deacetylase Inhibitors”. Current Topics in Medicinal Chemistry Vol. 10, no. (14), pp. 1423-40, 2010.
[53]  V. Patil, Guerrant., William Chen., C. Po, B. Gryder, Benicewicz, B. Derek, Khan, I. Shabana, Tekwani, L. Babu, Oyelere, K. Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol.18, pp. 415-425, 2010.
[54]  Druesne-Pecollo N, Latino-Martel P. Modulation of histone acetylation by garlic sulfur compounds. Anticancer Agents Med Chem. Vol.11, no. 3, pp. 254-9. 2011.
[55]  A.C. Chueh, J.W. Tse, L. Tögel, J.M. Mariadason, “Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells”. Antioxidants & Redox Signaling, Vol. 23, no. 1, pp. 66-84.
[56]  M.O. Altonsy, S.C. Andrews, “Diallyl disulphide, a beneficial component of garlic oil, causes a redistribution of cell-cycle growth phases, induces apoptosis, and enhances butyrate-induced apoptosis in colorectal adenocarcinoma cells (HT-29)”. Nutr Cancer, Vol. 63, no. (7), pp. 1104-13, 2011.
[57]  B. Pagliei, K. Aquilano, S. Baldelli, M.R. Ciriolo, “Garlic-derived diallyl disulfide modulates peroxisome proliferator activated receptor gamma co-activator 1 alpha in neuroblastoma cells”. Biochem Pharmacol. Vol. 85, no. 3, pp. 335-44, 2013.
[58]  Malumbres, Marcos; M. Barbacid, “Cell cycle, CDKs and cancer: a changing paradigm”. Nature Reviews Cancer, Vol. 9, PP. 153-166, 2009.
[59]  Julian Lewis, 2007. “Molecular biology of the cell “(5th ed.). New York: Garland Science.
[60]  K. Vermeulen, Van Bockstaele., R. Dirk, Berneman, N. Zwi, “The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer”. Cell Proliferation, Vol. 36, no. 3, pp. 131-149, 2003.
[61]  Herman-Antosiewicz, et al, “Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1”. Pharm Res. Vol. 27, no. 6, pp. 1072-9, 2010.
[62]  B. Czepukojc, A.K. Baltes, C. Cerella, M. Kelkel, U.M. Viswanathan, F. Salm, T. Burkholz, C.Schneider, M. Dicato, M. Montenarh, C. Jacob, M. Diederich, “Synthetic polysulfane derivatives induce cell cycle arrest and apoptotic cell death in human hematopoietic cancer cells”. Food Chem Toxicol. Vol. 64, pp. 249-57, 2014.
[63]  A. Arunkumar, M.R. Vijayababu, N. Srinivasan, M.M. Aruldhas, J. Arunakaran, “Garlic compound, diallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3”. Mol Cell Biochem. Vol. 288, no. 1-2, pp. 107-113, 2006.
[64]  P.P. Wu, H.W. Chung, K.C. Liu, R.S. Wu, J.S. Yang, N.Y. Tang, C. Lo, T.C. Hsia, C.C. Yu, F.S. Chueh, S.S. Lin, J.G. Chung, “Diallyl sulfide induces cell cycle arrest and apoptosis in HeLa human cervical cancer cells through the p53, caspase- and mitochondria-dependent pathways”. Int J Oncol. Vol. 38, no. 6, pp. 1605-13, 2011.
[65]  Y.L. Chu, C.T. Ho, J.G. Chung, R. Raghu, Y.C. Lo, L.Y. Sheen, “Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy”. J Agric Food Chem. Vol. 61, no. 41, pp. 9839-48, 2013.
[66]  S. van den Heuvel, N.J. Dyson, “Conserved functions of the pRB and E2F families”. Nat. Rev. Mol. Cell Biol. Vol. 9, pp. 713-24, 2008.
[67]  K.A. Cimprich, D. Cortez, “ATR: an essential regulator of genome integrity”. Nat. Rev. Mol. Cell Biol. Vol. 9, pp. 616-27, 2008.
[68]  H.C. Reinhardt, M.B. Yaffe, “Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2”. Curr. Opin. Cell Biol. Vol. 21, pp. 245-55, 2009.
[69]  Lindqvist, A., Rodrìguez-Bravo, V., Medema R.H., 2009. “The decision to enter mitosis: feedback and redundancy in the mitotic entry network”. J. Cell Biol. 185, vol.2, 193-202.
[70]  V. Pei Patil, Guerrant., William Chen., C. Po, B. Gryder., Benicewicz, B. Derek, Khan, I. Shabana, L. Tekwani, Babu, Oyelere, K. Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol. 18, pp. 415-425, 2010.
[71]  Kaschula CH, Hunter R, Stellenboom N, Caira MR, Winks S, Ogunleye T, Richards P, Cotton J, Zilbeyaz K, Wang Y, Siyo V, Ngarande E, Parker MI. Structure-activity studies on the anti-proliferation activity of ajoene analogues in WHCO1 oesophageal cancer cells. Eur J Med Chem.Vol.50, pp. 236-54, 2012
[72]  P. Pratheeshkumar, P. Thejass, G. Kutan, “Diallyl disulfide induces caspase-dependent apoptosis via mitochondria-mediated intrinsic pathway in B16F-10 melanoma cells by up-regulating p53, caspase-3 and down-regulating pro-inflammatory cytokines and nuclear factor-κβ-mediated Bcl-2 activation”. J Environ Pathol Toxicol Oncol. Vol. 29, pp. 113-25, 2010.
[73]  Herman-Antosiewicz, “Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1”. Pharm Res. Vol. 27, pp. 1072-9, 2010.
[74]  D.Y. Shin, G.Y. Kim, J.I. Kim, M.K. Yoon, T.K. Kwon, S.J. Lee, Y.W. Choi, H.S. Kang, Y.H. Yoo, Y.H. Choi, “Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells”. Toxicol In Vitro. Vol. 24, pp. 1569-76, 2010.
[75]  Ji C, Ren F, Xu M. Caspase-8 and p38MAPK in DATS-induced apoptosis of human CNE2 cells. Braz J Med Biol Res. 2010; 43(9): 821-7.
[76]  Shrotriya S, Kundu JK, Na HK, Surh YJ. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling. Cancer Res. 2010; 70(5): 1932-40.
[77]  A. Musacchio, “Spindle assembly checkpoint: the third decade”. Philos. Trans. R. Soc. Lond., B, Biol. Sci. Vol. 366, no. 1584, pp. 3595-604, 2011
[78]  C.J. Lord, A. Ashworth, “The DNA damage response and cancer therapy”. Nature Vol. 481, no. 7381, pp.287-94, 2012.
[79]  L. Wohlbold, R.P. Fisher “Behind the wheel and under the hood: functions of cyclin-dependent kinases in response to DNA damage”. DNA Repair (Amst.) Vol. 8, pp.1018-24, 2009.
[80]  J.R. Skaar, M. Pagano, “Control of cell growth by the SCF and APC/C ubiquitin ligases”. Curr. Opin. Cell Biol. Vol. 21, pp. 816-24, 2009.
[81]  S. Kim, H. Yu, “Mutual regulation between the spindle checkpoint and APC/C’. Semin. Cell Dev. Biol. Vol. 22, pp. 551-8, 2011.
[82]  T. Devasagayam, J.C. Tilak, K.K. Boloor, Sane, S. Ketaki, S. Ghaskadbi Saroj, R.D. Lele, “Free Radicals and Antioxidants in Human Health: Current Status and Future Prospects”. Journal of Association of Physicians of India (JAPI) Vol. 52, pp. 796, 2004.
[83]  M.E. Sosa Torres, J.P. Saucedo-Vázquez, P.M. Kroneck, Chapter 1, Section 3 The dark side of dioxygen”. In Kroneck PM, Torres ME. Sustaining Life on Planet Earth: Metalloenzymes Mastering Dioxygen and Other Chewy Gases. Metal Ions in Life Sciences 15. Springer. pp. 1-12, 2015.
[84]  F. Muller, “The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging”. Journal of the American Aging Association Vol. 23, pp. 227-53, 2000.
[85]  D. Han, E. Williams, E. Cadenas, “Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space”. The Biochemical Journal Vol. 353, pp. 411-6, 2001.
[86]  Q. Kong, J.A. Beel, K.O. Lillehei, “A threshold concept for cancer therapy”. Medical Hypotheses Vol. 55, pp. 29-35, 2000.
[87]  D. Trachootham, J. Alexandre, P. Huang, “Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?”. Nature Reviews. Drug Discovery. Vol.8, no. 7, pp. 579-91, 2009.
[88]  N. Morihara, M. Hayama, H. Fujii, “Aged garlic extract scavenges superoxide radicals”. Plant Foods Hum Nutr. Vol. 66, pp. 17-21, 2011.
[89]  K. Srinivasan, “Antioxidant potential of spices and their active constituents”. Crit Rev Food Sci Nutr. Vol. 54, no. 3, pp. 352-72, 2014.
[90]  Capasso A. Antioxidant action and therapeutic efficacy of Allium sativum L. Molecules. Vol. 18, no. 1, pp. 690-700, 2013.
[91]  K. Chandra-Kuntal, J. Lee, S.V. Singh, “Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic”. Breast Cancer Res Treat. Vol.138, pp. 69-79, 2013.
[92]  Saidu NE, Abu Asali I, Czepukojc B, Seitz B, Jacob C, Montenarh M. Comparison between the effects of diallyl tetrasulfide on human retina pigment epithelial cells (ARPE-19) and HCT116 cells. Biochim Biophys Acta.; Vo. 1830, no. 11, pp. 5267-76. 2013.
[93]  A. Djuv, O.G. Nilsen, A. Steinsbekk, “The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study”. BMC Complement Altern Med. Vol. 13, pp. 295, 2013.
[94]  V.M. Dirsch, A.L. Gerbes, A.M. Vollmar, “Ajoene, a compound of garlic, induces apoptosis in human promyeloleukemic cells, accompanied by generation of reactive oxygen species and activation of nuclear factor kappaB”. Mol Pharmacol. Vol. 53, no. 3, pp. 402-407, 1998.
[95]  Pinto JT, Rivlin RS. Antiproliferative effects of allium derivatives from garlic. J Nutr. Vol. 131, no. 3s, pp. 1058S-60S., 2001.
[96]  G.J. Blake, P.M. Ridker, K.M. Kuntz, “Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia”. Am J Med. Vol. 114, no.6, pp. 485-94, 2003.
[97]  M. Ali, M. Thomson, M. Afzal, “Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance”. Prostaglandins Leukot Essent Fatty Acids. Vol.62, no. 2: pp. 55-73, 2000.
[98]  E. Padilla-Camberos, G. Zaitseva, C. Padill, a, A.M. Puebla, “Antitumoral activity of allicin in murine lymphoma L5178Y”. Asian Pac J Cancer Prev. Vol. 11, no. 5, pp. 1241-4, 2010.
[99]  D. Xiao, J.T. Pinto, J.W. Soh, “Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation”. Cancer Res; Vol. 63, no. (20), pp. 6825-6837, 2003.
[100]  R. Bradley, J. Endres, D. Hockenberry, “Investigation of garlic-induced apoptosis in breast cancer cell lines”. International Scientific Conference on Complementary, Alternative and Integrative Medicine Research, Boston, MA., 2002.
[101]  Hu X, Cao BN, Hu G, et al. Attenuation of cell migration and induction of cell death by aged garlic extract in rat sarcoma cells. Int J Mol Med 2002; Vol. 9, 6, pp. 641-643.
[102]  C.M. Tilli, A.J. Stavast-Kooy, J.D. Vuerstaek, “The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis”. Arch Dermatol Res, vol. 295, no. (3), pp. 117-123, 2003.
[103]  M. Li, J.R. Ciu, Y. Ye, “Antitumor activity of Z-ajoene, a natural compound purified from garlic: antimitotic and microtubule-interaction properties”. Carcinogenesis. Vol. 23, no. 4, pp. 573-579, 2002.
[104]  N. Morioka, L.L. Sze, D.L. Morton, “A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A”. Cancer Immunol Immunother; Vol. 37, no. 5, pp. 316-322, 1993.
[105]  C.P. Siegers, B. Steffen, A. Robke, “The effects of garlic preparation against human tumour cell proliferation”. Phytomedicine Vol. 6, no. (1), pp.7-11, 1999.
[106]  J.A. Milner, “Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlicand carcinogenesis”. Adv Exp Med Biol. Vol. 492, pp. 69-81, 2001.
[107]  B.H. Lau, P.P. Tadi, J.M. Tosk, “Allium sativum (garlic) and cancer prevention”. Nutrit Res Vol. 10, pp. 937-948, 1990.
[108]  M.J. Wargovich, N. Uda, C.Woods, “Allium vegetables: their role in the prevention of cancer”. B2iochem Soc Transl Vol. 24, no. 3, pp. 811-814, 1996.
[109]  Z. Wang, Z. Liu, Z. Cao, L. Li, “Allicin induces apoptosis in EL-4 cells in vitro by activation of expression of caspase-3 and -12 and up-regulation of the ratio of Bax/Bcl-2”. Nat Prod Res. Vol. 26, no. 11, pp. 1033-7, 2012.
[110]  Y.M. Nkrumah-Elie, J.S. Reuben , A.M. Hudson, E. Taka, R. Badisa, T. Ardley, B. Israel, S.Y. Sadrud-Din, E.T. Oriaku, S.F. Darling-Reed, “The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells”. Nutr Cancer. Vol. 64, no. 7, pp. 1112-21, 2012.
[111]  A.K. Yang, S.M. He, L. Liu, J.P. Liu, M.Q. Wei, S.F. Zhou, “Herbal interactions with anticancer drugs: mechanistic and clinical considerations”. Curr Med Chem. Vol. 17, no. 16, pp. 1635-78, 2010.
[112]  E.J. Kim, D.H. Lee, H.J. Kim, S.J. Lee, J.O. Ban, M.C. Cho, H.S. Jeong, Y. Yang, J.T. Hong, Y. Yoon, do, “Thiacremonone, a sulfur compound isolated from garlic, attenuates lipid accumulation partially mediated via AMPK activation in 3T3-L1 adipocytes”. J Nutr Biochem. Vol. 23, no. 12, pp. 1552-8, 2012.
[113]  T. Kaneko, K. Shimpo, T. Chihara, H. Beppu, A. Tomatsu, M. Shinzato, T. Yanagida, T. S. Sonoda, A. Futamura, A. Ito, T.Higashiguchi, “Inhibition of ENNG-induced pyloric stomach and small intestinal carcinogenesis in mice by high temperature- and pressure-treated garlic”. Asian Pac J Cancer Prev. Vol. 13, no. 5, pp. 1983-8, 2012.
[114]  S.D. Stan, S.V. Singh, “Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide inhuman prostate cancer cells”. Clin Cancer Res. Vol. 15, no. 15, pp. 4895-903, 2009.
[115]  E.R. Hahm, S.V. Singh, “Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells”. Breast Cancer Res Treat. Vol. 144, no. 1, pp. 47-57, 2014.
[116]  D.P. Lane, “Cancer. p53, guardian of the genome”, Nature, Vol. 358, pp. 15-16, 1992.
[117]  H. Hu, X.P. Zhang, Y.L. Wang, C.W. Chua, S.U. Luk, Y.C. Wong, M.T. Ling, X.F. Wang, K.X. Xu, “Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells”. Mol Med Rep. Vol. 4, no. 1, pp. 9-16, 2011.
[118]  M.L. Antony, S.H. Kim, S.V. Singh, “Critical role of p53 upregulated modulator of apoptosis in benzyl isothiocyanate-induced apoptotic cell death”. PLoS One. Vol. 7, no. 2:e32267, 2012.
[119]  M. Iciek, I. Kwiecień, G. Chwatko, M. Sokołowska-Jeżewicz, D. Kowalczyk-Pachel, H. Rokita, “The effects of garlic-derived sulfur compounds on cell proliferation, caspase 3 activity, thiol levels and anaerobic sulfur metabolism in human hepatoblastoma HepG2 cells”. Cell Biochem Funct. Vol. 30, no. 3, pp. 198-204, 2012.
[120]  Lai KC, Hsu SC, Kuo CL, Yang JS, Ma CY, Lu HF, Tang NY, Hsia TC, Ho HC, Chung JG. Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions. Environ Toxicol. Vol. 28, no. 9: 479-88.
[121]  H.S. Park, G.Y. Kim, I.W. Choi, N.D. Kim, H.J. Hwang, Y.W. Choi, Y.H. Choi, “Inhibition of matrix metalloproteinase activities and tightening of tight junctions by dially l disulfide in AGS human gastric carcinoma cells”. J Food Sci. Vol. 76, no. 4, pp. 105-11, 2011.
[122]  Z. Liu, M. Li , K. Chen ,J. Yang , R. Chen ,T. Wang, J. Liu , W. Yang , Z. Ye. S-allylcysteine induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells. Mol Med Rep. Vol. 5, no. 2, pp. 439-43, 2012.
[123]  M.H. Pai, Y.H. Kuo, E.P. Chiang, F.Y. Tang, “S-Allylcysteine inhibits tumour progression and the epithelial-mesenchymal transition in a mouse xenograft model of oral cancer”. Br J Nutr. Vol. 108, no. 1, pp. 28-38, 2012
[124]  V. Pei Patil, Guerrant, William Chen., C. Po, B. Gryder., Benicewicz, B. Derek, Khan, I.Shabana, Tekwani, L.Babu, Oyelere, K.Adegboyega, “Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group”. Bioorganic & Medicinal Chemistry Vol.18, pp. 415-425, 2010.
[125]  K.T. Ng, D.Y. Guo, Q. Cheng, W. Geng, C.C. Ling, C.X. Li, X.B. Liu, Y.Y. Ma, C.M. Lo, R.T. Poon, S.T. Fan, K. Man, “A garlic derivative, S-allylcysteine (SAC), suppresses proliferation and metastasis of hepatocellular carcinoma”. PLoS One. Vol. 7, no. 2, e31655, 2012.
[126]  D.F. Romagnolo, CD Davis, JA Milner, “Phytoalexins in cancer prevention”. Front Biosci (Landmark Ed). Vol. 17, pp. 2035-58, 2012.
[127]  C.G. Yedjou, P.B. Tchounwou, “In vitro assessment of oxidative stress and apoptotic mechanisms of garlic extract in the treatment of acute promyelocytic leukemia”. J Cancer Sci Ther. (Suppl 3) 6, 2012.
[128]  Y.M. Nkrumah-Elie, J.S. Reuben, A.M. Hudson, E. Taka, R. Badisa, T. Ardley, B. Israel, S.Y. Sadrud-Din, E.T. Oriaku, S.F. Darling-Reed, “The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells”. Nutr Cancer. Vol. 64, no. 7, pp. 1112-21, 2012.
[129]  A. Borkowska, N. Knap, J. Antosiewicz, “Diallyl trisulfide is more cytotoxic to prostate cancer cells PC-3 than to noncancerous epithelial cell line PNT1A: a possible role of p66Shc signaling axis”. Nutr Cancer. Vol. 65, no. 5, pp. 711-7, 2013.
[130]  Y.S. Huang, N. Xie, Q. Su, J. Su, C. Huang, Q.J. Liao, “Diallyl disulfide inhibits the proliferation of HT-29 human colon cancer cells by inducing differentially expressed genes”. Mol Med Rep. Vol. 4, no. 3, pp. 553-9, 2011.
[131]  F.S. Yu, C.C. Wu, C.T. Chen, S.P. Huang, J.S. Yang, Y.M. Hsu, P.P. Wu, S.W. Ip, J.P. Lin, J.G. Lin, J.G. Chung, “Diallyl sulfide inhibits murine WEHI-3 leukemia cells in BALB/c mice in vitro and in vivo”. Hum Exp Toxicol. Vol. 12, pp. 785-90, 2009.
[132]  M.L. Antony, S.V. Singh, “Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide”. Indian J Exp Biol. Vol. 49, no. 11, pp. 805-16. 2011.
[133]  C.Y. Chen, C.F. Huang, Y.T. Tseng, S.Y. Kuo, “Diallyl disulfide induces Ca2+ mobilization in human colon cancer cell line SW480”. Arch Toxicol. Vol. 86, no. 2, pp. 231-8, 2012.
[134]  S. Modem, S.E. Dicarlo, T.R. Reddy, “Fresh Garlic Extract Induces Growth Arrest and Morphological Differentiation of MCF7 Breast Cancer Cells”. Genes Cancer.Vol. 3, no. 2, pp. 177-86, 2012.
[135]  K. Kashfi, K.R. Olson, “Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras”. Biochem Pharmacol. Vol. 85, no. 5, pp. 689-703, 2013.
[136]  E.D. Kantor, J.W. Lampe, T.L. Vaughan, U. Peter s, C.D. Rehm, E. White, “Association between use of specialty dietary supplements and C-reactive protein concentrations”. Am J Epidemiol. Vol. 176, no.11, pp. 1002-13, 2012.
[137]  R. Barr, K.Y. Chin, “Iatrogenic burns from garlic”. J Burn Care Res.Vol.34, no. 3, e214, 2013.
[138]  Zhang, C,L., Zeng, T, Zhao, X.L., Yu, L.H., Zhu, Z.P., Xie, K.Q., 2012. “Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats”. Int J Biol Sci. Vol. 8, no. 3, 363-74.
[139]  R. Nepravishta, R. Sabelli, E. Iorio, L. Micheli, M. Paci, S. Melino, “Oxidative species and S-glutathionyl conjugates in the apoptosis induction by allyl thiosulfate”. FEBS J. Vol. 279, pp. 154-67, 2012.
[140]  B. Ray, N.B. Chauhan, D.K. Lahiri, “The aged garlic extract: (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD)”. Curr Med Chem. Vol.18, no. 22, pp. 3306-13, 2011.
[141]  J.H. Jeong, H.R. Jeong, Y.N. Jo, H.J. Kim, J.H. Shin, H.J. Heo, “Ameliorating effects of aged garlic extracts against Aβ-induced neurotoxicity and cognitive impairment”. BMC Complement Altern Med.Vol.18, p. 268, 2013.
[142]  L. Yan, I.H. Kim, “Effects of dietary supplementation of fermented garlic powder on growth performance, apparent total tract digestibility, blood characteristics and faecal microbial concentration in weanling pigs”. J Anim Physiol Anim Nutr (Berl). Vol. 97, no. 3, pp.457-64, 2013.
[143]  J.S. Kang, T.M. Kim, T.J. Shim, E.I. Salim, B.S. Han, D.J. Kim, “Modifying effect of diallyl sulfide on colon carcinogenesis in C57BL/6J-ApcMin/⁺ mice”. Asian Pac J Cancer Prev. Vol. 13, no. 4, pp. 1115-8, 2012.
[144]  M.L. McCullough, E.J. Jacobs, R. Shah, P.T. Campbell, S.M. Gapstur, “Garlic consumption and colorectal cancer risk in the CPS-II Nutrition Cohort”. Cancer Causes Control. Vol. 23, no. 10, pp. 1643-51, 2012.
[145]  C.A. Gonzalez, L Lujan-Barroso, H.B. Bueno-de-Mesquita, M. Jenab, E.J. Duell, A. Agudo, A. Tjønneland, M.C. Boutron-Ruault, “Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study after a longer follow-up”. Int J Cancer. Vol. 131, no. 12, pp. 2910-9, 2012.
[146]  S.V. Rana, l R Pa,, K. Vaiphei, S.K. Sharma, R.P. Ola, “Garlic in health and disease”. Nutr Res Rev. Vol. 24, no. 1, pp. 60-71, 2011.
[147]  C. Cerella, M. Dicato, C. Jacob, M. Diederich, “Chemical properties and mechanisms determining the anti-cancer action of garlic-derived organic sulfur compounds”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 267-71, 2011.
[148]  A. Tsubura, Y.C. Lai, M. Kuwata, N. Uehara, K. Yoshizawa, “Anticancer effects of garlic and garlic-derived compounds for breast cancer control”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 249-53, 2011.
[149]  R.B. Walter, T.M. Brasky, F. Milano, E. White, “Vitamin, mineral, and specialty supplements and risk of hematologic malignancies in the prospective VITamins And Lifestyle (VITAL) study”. Cancer Epidemiol Biomarkers Prev. Vol. 20, no. 10, pp. 2298-308, 2011.
[150]  Brasky TM, Kristal AR, Navarro SL, Lampe JW, Peters U, Patterson RE, White E. Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutr Cancer. 2011; 63(4):573-82.
[151]  S. Karmakar, S.R. Choudhury, N.L. Banik, S.K. Ray, “Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma”. Anticancer Agents Med Chem. Vol. 11, no. 4, pp.398-407, 2011.
[152]  Bright-Gbebry M, Makambi KH, Rohan JP, Llanos AA, Rosenberg L, Palmer JR, Adams-Campbell LL. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study. BMC Complement Altern Med. 2011 11: 30.
[153]  H.M. Alkreathy, Z.A. Damanhouri, N. Ahmed, M. Slevin, A.M. Osman, “Mechanisms of cardioprotective effect of aged garlic extract against Doxorubicin-induced cardiotoxicity”. Integr Cancer Ther. Vol. 11, no. 4, pp. 364-70, 2012.
[154]  J.S. McLay, D. Stewar, t, J. George, C. Rore , S.D. Heys, “Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?” Eur J Clin Pharmacol. Vol. 68, no. 5, pp. 811-9, 2012.
[155]  M. Miroddi, F. Calapai, G. Calapai, “Potential beneficial effects of garlic in oncohematology”. Mini Rev Med Chem. Vol. 11, no. 6, pp. 461-72, 2011.
[156]  F.Y. Tang, E.P. Chiang, M.H. Pai, “Consumption of s-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model”. J Agric Food Chem. Vol. 58, no. 20, pp. 11156-64, 2010.
[157]  D. Liang, Y. Qin, W. Zhao, X. Zhai, Z. Guo, R, Wang, L. Tong, L. Lin, H. Chen, YC. Wong, Z. Zhong, “S-allylmercaptocysteine effectively inhibits the proliferation of colorectal cancer cells under in vitro and in vivo conditions”. Cancer Lett. Vol. 310, no. 1, pp. 69-76, 2011.
[158]  H. Javed, M.M. Khan, A. Khan, K. Vaibhav, A. Ahmad, G. Khuwaja, M.E. Ahmed, S.S. Raza, M. Ashafaq, R. Tabassum, M.S. Siddiqui, O.M. El-Agnaf, M.M. Safhi, F. Islam, “S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type”. Brain Res. 1389, pp. 133-42, 2011.
[159]  Y. Iitsuka, Y. Tanaka, T. Hosono-Fukao, T. Hosono, T. Seki, T. Ariga, “Relationship between lipophilicity and inhibitory activity against cancer cell growth of nine kinds of alk(en)yl trisulfides with different side chains”. Oncol Res. Vol.18, no. 11-12, pp. 575-82, 2010.
[160]  T. Zeng, Y. Li, C.L. Zhang, L.H. Yu, Z.P. Zhu, X.L. Zhao, K.Q. Xie, “Garlic oil suppressed the hematological disorders induced by chemotherapy and radiotherapy in tumor-bearing mice”. J Food Sci. Vol. 78, no. 6, pp. 936-42, 2013.
[161]  W Jiang, Y Huang, JP Wang, XY Yu, LY Zhang, The synergistic anticancer effect of artesunate combined with allicin in osteosarcoma cell line in vitro and in vivo”. Asian Pac J Cancer Prev. Vol. 14, no. 8, pp. 4615-9.
[162]  K. Berginc, A. Kristl, “The mechanisms responsible for garlic - drug interactions and their in vivo relevance”. Curr Drug Metab. Vol. 14, no. 1, pp. 90-101, 2013.
[163]  H. Shirzad, F. Taji, M. Rafieian-Kopaei, “Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice”. J Med Food. Vol. 14, no. 9, pp. 969-74, 2011.
[164]  L. Yi, Q. Su, “Molecular mechanisms for the anti-cancer effects of diallyl disulfide”. Food Chem Toxicol. Vol. 57, pp. 362-70, 2013.
[165]  N. Druesne-Pecollo, P. Latino-Martel, “Modulation of histone acetylation by garlic sulfur compounds”. Anticancer Agents Med Chem. Vol. 11, no. 3, pp. 254-9, 2011.
[166]  E. Viry, A. Anwar, G. Kirsch, C. Jacob, M. Diederich, D. Bagrel, “Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases”. Int J Oncol. Vol. 38, no. 4, pp. 1103-11, 2011.
[167]  V. Karagianni, E. Merikas, F. Georgopoulos, A. Gikas, N. Athanasopoulos, G. Malgarinos, G. Peros, J.K. Triantafillidis, “Risk factors for colorectal polyps: findings from a Greek case-control study”. Rev Med Chir Soc Med Nat Iasi. Vol.114, no. 3, pp. 662-70, 2013.
[168]  B. Akgül, K.W. Lin, Ou, H.M. Yang, Y.H. Chen,, T.H. Lu, C.H. Chen, T. Kikuchi, Y.T. Chen, C.P. Tu, “Garlic accelerates red blood cell turnover and splenic erythropoietic gene expression in mice: evidence for erythropoietin-independent erythropoiesis”. PLoS One. Vol. 5, no. 12, e15358, 2010.
[169]  T. Chihara, K. Shimpo, T. Kaneko, H. Beppu, K. Mizutani, T. Higashiguchi, S. Sonoda, “Inhibition of 1, 2-dimethylhydrazine-induced mucin-depleted foci and O⁶-methylguanine DNA adducts in the rat colorectum by boiled garlic powder”. Asian Pac J Cancer Prev. Vol. 11, no. 5, pp. 1301-4, 2010.
[170]  H. Hakimzadeh, T. Ghazanfari, B. Rahmati, H. Naderimanesh, “Cytotoxic effect of garlic extract and its fractions on Sk-mel3 melanoma cell line”. Immunopharmacol Immunotoxicol. Vol. 32, no. 3, pp. 371-5, 2010.
[171]  T. Ghazanfari, R. Yaraee, B. Rahmati, H. Hakimzadeh, J. Shams, M.R. Jalali-Nadoushan, “In vitro cytotoxic effect of garlic extract on malignant and nonmalignant cell lines”. Immunopharmacol Immunotoxicol. Vol. 33, no. 4, pp. 603-8, 2011.
[172]  M.S. Butt, M.T. Sultan, M.S. Butt, J. Iqbal, “Garlic: nature's protection against physiological threats”. Crit Rev Food Sci Nutr. Vol. 49, no. 6, pp. 538-51, 2009.
[173]  K. Lazarevic, A. Nagorni, N. Rancic, S. Milutinovic, L. Stosic, I. Ilijev, “Dietary factors and gastric cancer risk: hospital-based case control study”. J BUON. Vol. 15, no. 1, pp. 89-93, 2010.
[174]  S. Melino, R. Sabelli, M. Paci, “Allyl sulfur compounds and cellular detoxification system: effects and perspectives in cancer therapy”. Amino Acids. Vol. 41, no. 1, pp. 103-12, 2011.
[175]  A. Piasek, A. Bartoszek, J. Namieśnik, “Phytochemicals that counteract the cardiotoxic side effects of cancer chemotherapy”. Postepy Hig Med Dosw Vol. 63, pp. 142-58, 2009.
[176]  N.P. Gullett , A.R. Ruhul Amin, S. Bayraktar, J.M. Pezzuto, D.M. Shin, F.R. Khuri, B.B .Aggarwal, Y.J. Surh, O. Kucuk, “Cancer prevention with natural compounds”. Semin Oncol. Vol. 37, no. 3, pp. 258-81. 2010.
[177]  N. Ferrari, F. Tosetti, S. De Flora, F. Donatelli, I. Sogno, D.M. Noonan, A. Albini, “Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention”. Curr Drug Targets. Vol. 12, no. 13, pp. 1909-24, 2011.
[178]  S. Kweon, K.A. Park, H. Choi, “Chemopreventive effect of garlic powder diet in diethylnitrosamine-induced rat hepatocarcinogenesis”. Life Sci Vol. 73, no. 19, pp. 2515-2526, 2003.
[179]  M.C. Unnikrishnan, K.K. Soudamini, R. Kuttan, “Chemoprotection of garlic extract toward cyclophosphamide toxicity in mice”. Nutr Cancer Vol. 13, no.3, pp. 201-207, 1990.
[180]  M.I. Thabrew, N.A. Samarawickrema, L.G. Chandrasena, “Protection by garlic against adriamycin induced alterations in the oxido-reductive status of mouse red blood cells”. Phytother Res Vol. 14, no. 3, pp. 215-217, 2000.
[181]  S.P. Hussain, L.N. Jannu, A.R. Rao, “Chemopreventive action of garlic on methylcholanthrene-induced carcinogenesis in the uterine cervix of mice”. Cancer Lett. Vol. 49, no. 2, pp. 175-180, 1990.
[182]  S. Balasenthil, K.S. Rao, S. Nagini, “Retinoic acid receptor-beta mRNA expression during chemoprevention of hamster cheek pouch carcinogenesis by garlic”. Asia Pac J Clin Nutr, Vol. 12, no. 2, pp. 215-218, 2003.
[183]  B.H. Wang, K.A. Zuzel, K. Rahman, “Protective effects of aged garlic extract against bromobenzene toxicity to precision cut rat liver slices”. Toxicology. Vol.126, no. 3, pp. 213-222, 1998.
[184]  B.H. Wang, K.A. Zuzel, K. Rahman, “Treatment with aged garlic extract protects against bromobenzene toxicity to precision cut rat liver slices”. Toxicology. Vol. 132, no. 2-3, pp. 215-225, 1999.
[185]  C. Dwivedi, S. Rohlfs, D. Jarvis, “Chemoprevention of chemically induced skin tumor development by diallyl sulfide and diallyl disulfide”. Pharm Res. Vol. 9, no. 12, pp. 1668-1670, 1992.
[186]  V.L. Sparnins, G. Barany, L.W. Wattenberg, “Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse”. Carcinogenesis Vol. 9, no. 1, pp. 131-134, 1988.
[187]  Belman, S., 1983. “Onion and garlic oils inhibit tumor promotion”. Carcinogenesis. Vol.4, no. 8, pp. 1063-1065, 1988.
[188]  H. Nishino, A. Iwashima, Y. Itakura, “Antitumor-promoting activity of garlic extracts”. Oncology, Vol. 46 no. 4, pp. 277-280, 1989.
[189]  M.J. Wargovich, “Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer”. Carcinogenesis Vol. 8, no. 3, pp. 487-489, 1987.